131 related articles for article (PubMed ID: 37260052)
41. Assessment of retinoblastoma RNA reflux after intravitreal injection of melphalan.
Winter U; Nicolas M; Sgroi M; Sampor C; Torbidoni A; Fandiño A; Chantada GL; Munier FL; Schaiquevich P
Br J Ophthalmol; 2018 Mar; 102(3):415-418. PubMed ID: 29089355
[TBL] [Abstract][Full Text] [Related]
42. Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.
Solana-Altabella A; Valero S; Balaguer J; Escobar-Cava P; Barranco H; López E; Ribes-Artero H; Poveda JL
J Oncol Pharm Pract; 2020 Dec; 26(8):1829-1835. PubMed ID: 32063104
[TBL] [Abstract][Full Text] [Related]
43. INTRAVITREAL MELPHALAN FOR TREATMENT OF VITREOUS SEEDING FROM CHOROIDAL MELANOMA.
Masoomian B; Mashayekhi A; Malik K; Shields CL
Retin Cases Brief Rep; 2021 Mar; 15(2):97-100. PubMed ID: 30048404
[TBL] [Abstract][Full Text] [Related]
44. Intravitreal chemotherapy provides control for massive vitreous seeding from retinoblastoma.
Lawson BM; Saktanasate J; Say EA; Shields CL
J Pediatr Ophthalmol Strabismus; 2014 Dec; 51 Online():e92-4. PubMed ID: 25490242
[TBL] [Abstract][Full Text] [Related]
45. Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds.
Smith SJ; Pulido JS; Salomão DR; Smith BD; Mohney B
Br J Ophthalmol; 2012 Aug; 96(8):1073-7. PubMed ID: 22368261
[TBL] [Abstract][Full Text] [Related]
46. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
Peterson EC; Elhammady MS; Quintero-Wolfe S; Murray TG; Aziz-Sultan MA
J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
[TBL] [Abstract][Full Text] [Related]
47. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
Shields CL; Bianciotto CG; Jabbour P; Ramasubramanian A; Lally SE; Griffin GC; Rosenwasser R; Shields JA
Arch Ophthalmol; 2011 Nov; 129(11):1399-406. PubMed ID: 21670328
[TBL] [Abstract][Full Text] [Related]
48. Anterior Ocular Toxicity of Intravitreous Melphalan for Retinoblastoma.
Francis JH; Marr BP; Brodie SE; Abramson DH
JAMA Ophthalmol; 2015 Dec; 133(12):1459-63. PubMed ID: 26378741
[TBL] [Abstract][Full Text] [Related]
49. Therapy for Vitreous Seeding Caused by Retinoblastoma. A Review.
Kodetová M; Švojgr K; Širc J; Vaněček J; Pochop P
Cesk Slov Oftalmol; 2024; 80(3):123-129. PubMed ID: 38538290
[TBL] [Abstract][Full Text] [Related]
50. Ten-year experience with intracameral chemotherapy for aqueous seeding in retinoblastoma: long-term efficacy, safety and toxicity.
Stathopoulos C; Beck-Popovic M; Moulin AP; Munier FL
Br J Ophthalmol; 2023 Dec; 108(1):124-130. PubMed ID: 36379686
[TBL] [Abstract][Full Text] [Related]
51. Successful treatment of ciliary body medulloepithelioma with intraocular melphalan chemotherapy: a case report.
Stathopoulos C; Gaillard MC; Schneider J; Munier FL
BMC Ophthalmol; 2020 Jun; 20(1):239. PubMed ID: 32552699
[TBL] [Abstract][Full Text] [Related]
52. Comparison of efficacy and toxicity of intravitreal melphalan formulations for retinoblastoma.
Hsieh T; Liao A; Francis JH; Lavery JA; Mauguen A; Brodie SE; Abramson DH
PLoS One; 2020; 15(7):e0235016. PubMed ID: 32609726
[TBL] [Abstract][Full Text] [Related]
53. Is intravitreal topotecan toxic to retinal function?
Nadelmann J; Francis JH; Brodie SE; Muca E; Abramson DH
Br J Ophthalmol; 2021 Jul; 105(7):1016-1018. PubMed ID: 32665221
[TBL] [Abstract][Full Text] [Related]
54. Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma.
Rao R; Honavar SG; Sharma V; Reddy VAP
Br J Ophthalmol; 2018 Apr; 102(4):490-495. PubMed ID: 28844050
[TBL] [Abstract][Full Text] [Related]
55. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
[TBL] [Abstract][Full Text] [Related]
56. Ocular and systemic toxicity of high-dose intravitreal topotecan in rabbits: Implications for retinoblastoma treatment.
Del Sole MJ; Clausse M; Nejamkin P; Cancela B; Del Río M; Lamas G; Lubieniecki F; Francis JH; Abramson DH; Chantada G; Schaiquevich P
Exp Eye Res; 2022 May; 218():109026. PubMed ID: 35276184
[TBL] [Abstract][Full Text] [Related]
57. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
[TBL] [Abstract][Full Text] [Related]
58. Intravitreal Carboplatin as Salvage Treatment for Progressive Vitreous Disease in Retinoblastoma: A Phase I Clinical Trial.
King BA; Wilson MW; Kaluzny T; Meredith C; Overbey-Canon J; Chiang J; Brennan RC
Ophthalmol Retina; 2023 Apr; 7(4):354-359. PubMed ID: 36372348
[TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma.
Daniels AB; Froehler MT; Pierce JM; Nunnally AH; Calcutt MW; Bridges TM; LaNeve DC; Williams PE; Boyd KL; Reyzer ML; Lindsley CW; Friedman DL; Richmond A
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):446-454. PubMed ID: 29368001
[TBL] [Abstract][Full Text] [Related]
60. Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review.
Smith SJ; Smith BD; Mohney BG
Br J Ophthalmol; 2014 Mar; 98(3):292-7. PubMed ID: 24187047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]